Happiness Development Group Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HAPP research report →
Companywww.happ.org.cn
Happiness Development Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures.
- CEO
- Xuezhu Wang
- IPO
- 2019
- Employees
- 218
- HQ
- Nanping, CN
Price Chart
Valuation
- Market Cap
- $31.30M
- P/E
- -0.17
- P/S
- 0.35
- P/B
- 0.12
- EV/EBITDA
- -0.31
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 4.15%
- Op Margin
- -53.16%
- Net Margin
- -60.37%
- ROE
- -62.50%
- ROIC
- -54.43%
Growth & Income
- Revenue
- $89.49M · 25.19%
- Net Income
- $-54,020,081 · -7906.87%
- EPS
- $-26.69 · -4548.33%
- Op Income
- $-47,576,051
- FCF YoY
- -3183.72%
Performance & Tape
- 52W High
- $7.40
- 52W Low
- $2.08
- 50D MA
- $5.11
- 200D MA
- $4.01
- Beta
- 0.22
- Avg Volume
- 16.06K
Get TickerSpark's AI analysis on HAPP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HAPP Coverage
We haven't published any research on HAPP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HAPP Report →